How to make an undruggable enzyme druggable: lessons from ras proteins

Area of Science:

• Oncology
• Biochemistry
• Computational Biology

Background:

• Ras proteins are key signaling molecules implicated in cancer development.
• Mutations in Ras proteins are found in up to 25% of human cancers.
• Targeting Ras proteins presents a significant challenge in drug discovery.

Purpose of the Study:

• To review advances in discovering allosteric inhibitors for Ras proteins.
• To highlight the role of computational techniques in identifying drug targets.
• To discuss potential applications of Ras research to other challenging drug targets.

Main Methods:

• Utilizing computational techniques to identify and characterize allosteric ligand-binding sites on Ras proteins.
• Screening ligand libraries against identified binding sites.
• Integrating computational findings with biophysical, structural, biochemical, and cell biological experimental data.

Main Results:

• Significant progress has been made in identifying allosteric inhibitors for Ras proteins.
• Computational approaches have proven effective in drug target identification and screening.
• A combination of computational and experimental methods is yielding promising therapeutic candidates.

Conclusions:

• Allosteric inhibitors for Ras proteins are emerging as promising cancer therapeutics.
• Lessons learned from Ras research can inform strategies for targeting similar proteins.
• The integration of computational and experimental approaches is crucial for advancing drug discovery for challenging targets.